219 related articles for article (PubMed ID: 10679091)
21. Uncoupling of proliferation and Stat5 activation in thymic stromal lymphopoietin-mediated signal transduction.
Isaksen DE; Baumann H; Zhou B; Nivollet S; Farr AG; Levin SD; Ziegler SF
J Immunol; 2002 Apr; 168(7):3288-94. PubMed ID: 11907084
[TBL] [Abstract][Full Text] [Related]
22. IL-4 selectively inhibits IL-2-triggered Stat5 activation, but not proliferation, in human T cells.
Castro A; Sengupta TK; Ruiz DC; Yang E; Ivashkiv LB
J Immunol; 1999 Feb; 162(3):1261-9. PubMed ID: 9973378
[TBL] [Abstract][Full Text] [Related]
23. Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor beta chain but is not essential for the proliferative signal transmission.
Fujii H; Nakagawa Y; Schindler U; Kawahara A; Mori H; Gouilleux F; Groner B; Ihle JN; Minami Y; Miyazaki T
Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5482-6. PubMed ID: 7777534
[TBL] [Abstract][Full Text] [Related]
24. Differential STAT5 signaling by ligand-dependent and constitutively active cytokine receptors.
Moucadel V; Constantinescu SN
J Biol Chem; 2005 Apr; 280(14):13364-73. PubMed ID: 15677477
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator of transcription 5) but not AP-1.
Biola A; Lefebvre P; Perrin-Wolff M; Sturm M; Bertoglio J; Pallardy M
Mol Endocrinol; 2001 Jul; 15(7):1062-76. PubMed ID: 11435608
[TBL] [Abstract][Full Text] [Related]
26. Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation.
Kieslinger M; Woldman I; Moriggl R; Hofmann J; Marine JC; Ihle JN; Beug H; Decker T
Genes Dev; 2000 Jan; 14(2):232-44. PubMed ID: 10652277
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
[TBL] [Abstract][Full Text] [Related]
28. Signaling through the interleukin 2 receptor beta chain activates a STAT-5-like DNA-binding activity.
Gaffen SL; Lai SY; Xu W; Gouilleux F; Groner B; Goldsmith MA; Greene WC
Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7192-6. PubMed ID: 7543676
[TBL] [Abstract][Full Text] [Related]
29. FVIIa:TF induces cell survival via G12/G13-dependent Jak/STAT activation and BclXL production.
Versteeg HH; Spek CA; Slofstra SH; Diks SH; Richel DJ; Peppelenbosch MP
Circ Res; 2004 Apr; 94(8):1032-40. PubMed ID: 15016732
[TBL] [Abstract][Full Text] [Related]
30. Stromal cells provide signals different from cytokines for STAT5 activation in hematopoietic cells.
Sato AK; Yanai N; Okubo T; Mori KJ; Obinata M
Cell Struct Funct; 2001 Apr; 26(2):95-101. PubMed ID: 11482458
[TBL] [Abstract][Full Text] [Related]
31. Induction of interleukin-2 receptor alpha (IL-2Ralpha) expression by interleukin-2: important role of the interleukin-2 receptor beta chain region between the two Stat5 docking sites.
Imbert V; Rezzonico R; Reichenbach P; Nabholz M
Eur Cytokine Netw; 2002; 13(3):331-9. PubMed ID: 12231477
[TBL] [Abstract][Full Text] [Related]
32. Interferon-alpha activates multiple STAT proteins and upregulates proliferation-associated IL-2Ralpha, c-myc, and pim-1 genes in human T cells.
Matikainen S; Sareneva T; Ronni T; Lehtonen A; Koskinen PJ; Julkunen I
Blood; 1999 Mar; 93(6):1980-91. PubMed ID: 10068671
[TBL] [Abstract][Full Text] [Related]
33. Role of STAT5 in interferon-alpha signal transduction in Ba/F3 cells.
Jaster R; Tschirch E; Bittorf T; Brock J
Cell Signal; 1999 May; 11(5):331-5. PubMed ID: 10376805
[TBL] [Abstract][Full Text] [Related]
34. Cooperative and redundant effects of STAT5 and Ras signaling in BCR/ABL transformed hematopoietic cells.
Hoover RR; Gerlach MJ; Koh EY; Daley GQ
Oncogene; 2001 Sep; 20(41):5826-35. PubMed ID: 11593388
[TBL] [Abstract][Full Text] [Related]
35. IL-7 reconstitutes multiple aspects of v-Abl-mediated signaling.
Banerjee A; Rothman P
J Immunol; 1998 Nov; 161(9):4611-7. PubMed ID: 9794389
[TBL] [Abstract][Full Text] [Related]
36. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.
Zhang Q; Nowak I; Vonderheid EC; Rook AH; Kadin ME; Nowell PC; Shaw LM; Wasik MA
Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9148-53. PubMed ID: 8799169
[TBL] [Abstract][Full Text] [Related]
37. NF-kappa B/Rel participation in the lymphokine-dependent proliferation of T lymphoid cells.
Mora A; Youn J; Keegan A; Boothby M
J Immunol; 2001 Feb; 166(4):2218-27. PubMed ID: 11160275
[TBL] [Abstract][Full Text] [Related]
38. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
[TBL] [Abstract][Full Text] [Related]
39. Signal transducer and activator of transcription 5a (STAT5a) is required for eosinophil differentiation of human cord blood-derived CD34+ cells.
Buitenhuis M; Baltus B; Lammers JW; Coffer PJ; Koenderman L
Blood; 2003 Jan; 101(1):134-42. PubMed ID: 12393707
[TBL] [Abstract][Full Text] [Related]
40. Distinct tyrosine residues within the interleukin-2 receptor beta chain drive signal transduction specificity, redundancy, and diversity.
Gaffen SL; Lai SY; Ha M; Liu X; Hennighausen L; Greene WC; Goldsmith MA
J Biol Chem; 1996 Aug; 271(35):21381-90. PubMed ID: 8702919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
